Retour
Fourchette du Jour
23,99 €
25,00 €
Fourchette 52 Semaines
8,58 €
25,44 €
Volume
883 520
Moyenne 50J / 200J
21,50 €
/
16,47 €
Clôture Précédente
24,23 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -7,4 | 0,4 |
| P/B | 32,9 | 2,9 |
| ROE % | -161,8 | 3,8 |
| Net Margin % | -165,6 | 3,9 |
| Rev Growth 5Y % | 5,4 | 10,0 |
| D/E | 5,4 | 0,2 |
Points Clés
Revenue grew 5,39% annually over 5 years — modest growth
Debt/Equity of 5,36 — high leverage
Negative free cash flow of -323,17M
PEG of 0,55 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 622,45%
Capital efficient — spends only 0,11% of revenue on capex
Croissance
Revenue Growth (5Y)
5,39%
Revenue (1Y)627,84%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-161,82%
ROIC-49,82%
Net Margin-165,60%
Op. Margin-158,45%
Sécurité
Debt / Equity
5,36
Current Ratio4,40
Interest Coverage-8,08
Valorisation
P/E Ratio
-7,44
P/B Ratio32,88
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 627,84% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 5,39% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 172,35M | Net Income (TTM) | -285,42M |
| ROE | -161,82% | ROA | -53,88% |
| Gross Margin | 95,96% | Operating Margin | -158,45% |
| Net Margin | -165,60% | Free Cash Flow (TTM) | -323,17M |
| ROIC | -49,82% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 5,36 | Current Ratio | 4,40 |
| Interest Coverage | -8,08 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -7,44 | P/B Ratio | 32,88 |
| P/S Ratio | 12,33 | PEG Ratio | 0,55 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 2,12B | Enterprise Value | 2,34B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 172,35M | 23,68M | 0,0 | 0,0 | 139,71M |
| Net Income | -285,42M | -318,76M | -209,36M | -149,34M | 24,93M |
| EPS (Diluted) | -3,30 | -3,73 | -2,98 | -2,46 | 0,48 |
| Gross Profit | 165,38M | 22,85M | 0,0 | 0,0 | 139,71M |
| Operating Income | -273,08M | -339,67M | -229,95M | -151,76M | 26,22M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 529,71M | 724,82M | 612,88M | 497,24M | 449,66M |
| Total Liabilities | 465,08M | 436,69M | 58,68M | 29,79M | 41,29M |
| Shareholders' Equity | 64,63M | 288,12M | 554,20M | 467,45M | 408,37M |
| Total Debt | 346,48M | 345,74M | 1,64M | 1,16M | 20,97M |
| Cash & Equivalents | 134,93M | 154,08M | 295,39M | 74,36M | 221,97M |
| Current Assets | 528,08M | 603,06M | 580,88M | 489,79M | 448,40M |
| Current Liabilities | 120,12M | 103,55M | 58,10M | 29,07M | 20,68M |